Argentine Vaccine Test Not a Secret

To describe the recent test of a vaccinia recombinant rabies vaccine in Argentine cattle as an attempt to avoid or sidestep governmental regulations of the United States and Argentina totally mistakes the motivation for conducting the test and what actually occurred. The test was conducted in Argentina not to evade U.S. regulations but because rabies is a problem of such magnitude among Argentine cattle. The Argentine test was not conducted in secret, as stated in your article [see p. 11]. Befor

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

To describe the recent test of a vaccinia recombinant rabies vaccine in Argentine cattle as an attempt to avoid or sidestep governmental regulations of the United States and Argentina totally mistakes the motivation for conducting the test and what actually occurred. The test was conducted in Argentina not to evade U.S. regulations but because rabies is a problem of such magnitude among Argentine cattle.

The Argentine test was not conducted in secret, as stated in your article [see p. 11]. Before the uproar that ensued in Argentina in September, the Argentine scientist in charge of rabies research at Cepanzo (Azul) had publicly reported on the test. In addition, Dr. F. Assad, director of the Infectious Diseases Program of WHO, announced the trial at an open symposium on vaccines held at Cold Spring Harbor, N.Y., in September 1986. In spite of this, PAHO representatives have since stated that, in retrospect, they ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Hilary Koprowski

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo